-+ 0.00%
-+ 0.00%
-+ 0.00%

Incannex backs White House order to speed access to psychedelic mental health treatments

PUBT·04/22/2026 12:09:06
Listen to the news
Incannex backs White House order to speed access to psychedelic mental health treatments
  • Incannex backed White House Executive Order signed April 18, 2026, aimed at accelerating access to medical treatments for serious mental illness.
  • CEO Joel Latham said order could speed regulatory pathways for PSX-001, Incannex oral synthetic psilocybin candidate for generalized anxiety disorder.
  • Incannex cited Phase 2 results showing 12.8-point reduction in HAM-A score versus 3.6 for placebo (p<0.0001).
  • Company said it held over $70 million cash with no debt, citing reduced regulatory and commercial risk for psilocybin class under order.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incannex Healthcare Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220800PRIMZONEFULLFEED9694716) on April 22, 2026, and is solely responsible for the information contained therein.